Tocilizumab in COVID-19 therapy: who benefits, and how? Yang C, Zhao H. Lancet 2021;398:299.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang C, Zhao H. Tocilizumab in COVID-19 therapy: who benefits, and how? Lancet 2021;398:299.
PMID: 34303431